Mild cognitive impairment in dementia with Lewy bodies: an update and outlook
KA Jellinger - Journal of Neural Transmission, 2023 - Springer
Dementia with Lewy bodies (DLB), the second most common degenerative neurocognitive
disorder after Alzheimer disease (AD), is frequently preceded by a period of mild cognitive …
disorder after Alzheimer disease (AD), is frequently preceded by a period of mild cognitive …
Differential and subtype-specific neuroimaging abnormalities in amnestic and nonamnestic mild cognitive impairment: A systematic review and meta-analysis
While mild cognitive impairment (MCI) has been classified into amnestic MCI (aMCI) and
nonamnestic MCI (naMCI), the neuropathological bases of these two subtypes remain …
nonamnestic MCI (naMCI), the neuropathological bases of these two subtypes remain …
Research diagnostic criteria for mild cognitive impairment with Lewy bodies: a systematic review and meta‐analysis
PC Donaghy, C Carrarini, D Ferreira… - Alzheimer's & …, 2023 - Wiley Online Library
Introduction Operationalized research criteria for mild cognitive impairment with Lewy
bodies (MCI‐LB) were published in 2020. The aim of this systematic review and meta …
bodies (MCI‐LB) were published in 2020. The aim of this systematic review and meta …
[HTML][HTML] Electroencephalography and mild cognitive impairment research: A scoping review and bibliometric analysis (ScoRBA)
Mild cognitive impairment (MCI) is often considered a precursor to Alzheimer's disease (AD)
and early diagnosis may help improve treatment effectiveness. To identify accurate MCI …
and early diagnosis may help improve treatment effectiveness. To identify accurate MCI …
Quantitative electroencephalography (qEEG), apolipoprotein AI (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive …
X Niu, Y Wang, X Zhang, Y Wang, W Shao, L Chen… - Neurological …, 2024 - Springer
Introduction Alzheimer's disease (AD) is the most common type of dementia. Amnestic mild
cognitive impairment (aMCI), a pre-dementia stage is an important stage for early diagnosis …
cognitive impairment (aMCI), a pre-dementia stage is an important stage for early diagnosis …
Comparative analysis of machine learning algorithms for Alzheimer's disease classification using EEG signals and genetic information
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
cognitive decline, memory impairments, and behavioral changes. The presence of abnormal …
cognitive decline, memory impairments, and behavioral changes. The presence of abnormal …
Electroencephalography in young onset dementia
CW Brown, HY Chen, PK Panegyres - BMC neurology, 2023 - Springer
Background Young onset dementia (YOD) is a major diagnostic and management problem.
Methods We set out to explore if electroencephalography (EEG) might be useful in the …
Methods We set out to explore if electroencephalography (EEG) might be useful in the …
Quantitative EEG Spectral and Connectivity Analysis for Cognitive Decline in Amnestic Mild Cognitive Impairment
K Zawiślak-Fornagiel, D Ledwoń… - Journal of …, 2024 - content.iospress.com
Background: Mild cognitive impairment (MCI) is considered to be the borderline of cognitive
changes associated with aging and very early dementia. Cognitive functions in MCI can …
changes associated with aging and very early dementia. Cognitive functions in MCI can …
[HTML][HTML] Resting state EEG relates to short-and long-term cognitive functioning after cardiac arrest
AB Glimmerveen, M Verhulst, NLM de Kruijf, P van Gils… - Resuscitation, 2024 - Elsevier
Background Approximately half of cardiac arrest survivors have persistent cognitive
impairment. Guidelines recommend early screening to identify patients at risk for cognitive …
impairment. Guidelines recommend early screening to identify patients at risk for cognitive …
Analysis of individual alpha frequency in a large cohort from a tertiary memory center
G Cecchetti, F Agosta, E Canu, S Basaia… - European Journal of …, 2024 - Wiley Online Library
Abstract Background and Purpose Precise and timely diagnosis is crucial for the optimal use
of emerging disease‐modifying treatments for Alzheimer disease (AD) …
of emerging disease‐modifying treatments for Alzheimer disease (AD) …